We can't find the internet
Attempting to reconnect
18024.1 PFLS-LS
Microfluidic two-tissue platform for combined drug efficacy and toxicity testing
Zusammenfassung
Microfluidic two-tissue platform for combined drug efficacy and toxicity testing
Weitere Texte
Abstract
Development and commercialization of an end-user validated microphysiological testing platform for combined drug efficacy and toxicity testing. The platform will rely on microfluidics technology and will enable to metabolically interconnect active human 3D liver microtissues with microtissue tumor models. Handling, operation and read-out will be made compatible with cell culturing standards.
Beteiligte
Jens M. Kelm
Wirtschaftspartner
jens.kelm@insphero.com
InSphero AG CHE-114.790.768 Jens M. Kelm Wagistrasse 27 8952 Schlieren ZH CH
Andreas Hierlemann
Kontaktperson
andreas.hierlemann@bsse.ethz.ch
ETH Zürich department of biosystems science an D-BSSE Andreas Hierlemann Mattenstrasse 26 4058 Basel BS CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2016-02-29
- Enddatum
- 2020-02-29
- Bewilligte Gesamtkosten
- CHF 705676.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%